The 2nd Innate Killer Europe Summit will gather 80+ key European Gamma Delta T, NK, iNKT, neutrophil, and macrophage developers in October to chase the holy grail of efficacious, off-the-shelf, solid tumour immunotherapies through effective and scalable engineering, engager and combination strategies that promote safe, potent and persistent innate immune therapies following application.